Delivery Order SPE2DB20D3303-SPE2DB23FA0UT
Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,738.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately 2,000 ml of the drug to support DLA's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its extensive distribution network and pharmaceutical supply chain expertise. No subcontractors or set aside designations were specified. This delivery order was...
- The Defense Logistics Agency awarded a $43,565.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver approximately 2,000 pens of the drug to a facility in Conshohocken, Pennsylvania over a one day period in late July 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order from its corporate offices to...
- The Defense Logistics Agency awarded a $35,472.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will provide approximately 2,000 pens of the injectable drug to support DLA's medical supply needs. As the prime, Amerisourcebergen will perform the order itself out of its Conshohocken, Pennsylvania distribution facility. No subcontractors or set aside designations were specified. This award is...
- The Defense Logistics Agency awarded a $37,590 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this order, Amerisourcebergen will deliver approximately 2,000 pens of the injectable drug to a location in Conshohocken, Pennsylvania by September 11, 2023 in support of Department of Defense pharmaceutical needs. As a major pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor program on an...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The award, valued at $5,921.36, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a $6,721.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The delivery order was issued under an existing prime vendor contract vehicle and calls for Amerisourcebergen to supply 2ML pens of the drug to a Defense Logistics Agency location in Conshohocken, Pennsylvania. Performance is required from July 7-10, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The Defense Logistics Agency awarded a $5,001.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
- The Defense Logistics Agency awarded a $32,580.15 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver approximately 2,000 pens of the drug to a facility in Conshohocken, Pennsylvania over a two day period in early July 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FA0UTDelivery Order
The Defense Logistics Agency awarded a $10,000.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately 2,000 units of the drug to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its extensive distribution network and pharmaceutical supply chain expertise. No subcontractors or set aside designations were specified. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle and will ensure service members have access to critical medications through August 2021.
Generated 12/15/23, 11:49 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/18/23 |